Indoco Remedies declared their Q2 FY24 results on 19 Oct, 2023. The topline increased by 11.24% & the profit decreased by 29.46% YoY. As compared to the previous quarter the revenue grew by 12.95% and the profit increased by 43.83%.
The Selling, general & administrative expenses rose by 0.63% q-o-q & increased by 14.56% Y-o-Y.
The operating income was up by 21% q-o-q & decreased by 30.8% Y-o-Y.
The EPS is ₹3.82 for Q2 FY24 which decreased by 29.26% Y-o-Y.
Indoco Remedies has delivered 3.29% return in the last 1 week, 11.95% return in last 6 months and -13.83% YTD return.
Currently the Indoco Remedies has a market cap of ₹3228.95 Cr and 52wk high/low of ₹423.9 & ₹306.4 respectively.
As of 21 Oct, 2023 out of 6 analysts covering the company, 3 analysts have given Hold rating, 1 analyst has given Buy rating &2 analysts have given Strong Buy rating.
The consensus recommendation as on 21 Oct, 2023 was to Buy.
Indoco Remedies Financials
Period | Q2 FY24 | Q1 FY24 | Q-o-Q Growth | Q2 FY23 | Y-o-Y Growth |
---|---|---|---|---|---|
Total Revenue | 481.73 | 426.5 | +12.95% | 433.04 | +11.24% |
Selling/ General/ Admin Expenses Total | 92.12 | 91.54 | +0.63% | 80.41 | +14.56% |
Depreciation/ Amortization | 21.41 | 19.88 | +7.7% | 15.65 | +36.81% |
Total Operating Expense | 431.77 | 385.21 | +12.09% | 360.84 | +19.66% |
Operating Income | 49.96 | 41.29 | +21% | 72.2 | -30.8% |
Net Income Before Taxes | 46.28 | 33.91 | +36.48% | 67.3 | -31.23% |
Net Income | 35.08 | 24.39 | +43.83% | 49.73 | -29.46% |
Diluted Normalized EPS | 3.82 | 2.62 | +45.8% | 5.4 | -29.26% |
Catch all the Business News , Corporate news , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.